Valproic Acid Enhances the Anti-tumor Effect of Pegylated Interferon-α Towards Pancreatic Cancer Cell Lines

被引：0

作者：

Sugimoto, Koji ^{[1
]}

Shimada, Mitsuo ^{[1
]}

Utsunomiya, Toru ^{[1
]}

Morine, Yuji ^{[1
]}

Imura, Satoru ^{[1
]}

Ikemoto, Tetsuya ^{[1
]}

Iwahashi, Shuichi ^{[1
]}

机构：

[1] Univ Tokushima, Dept Surg, Inst Hlth Biosci, Tokushima 7708503, Japan

来源：

ANTICANCER RESEARCH | 2014年 / 34卷 / 07期

关键词：

Histone deacetylase inhibitor; valproic acid; pegylated interferon-alpha; pancreatic cancer; HISTONE DEACETYLASE INHIBITORS; REGULATORY FACTOR-8; IN-VITRO; COMBINATION THERAPY; IFN-ALPHA; EXPRESSION; APOPTOSIS; ANGIOGENESIS; REGRESSION; CARCINOMA;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Valproic acid (VPA) acts as a specific inhibitor of class I HDACs and it use has been proven to be safe since a long time. Materials and Methods: In the present study, we investigated the effect of VPA in the combination with pegylated interferon-alpha (PEG-IFN alpha) in inhibition of cell proliferation of human pancreatic cancer cell lines. Results: VPA enhanced the effect of PEG-IFNa, and the effect was decreased by the caspase inhibitor. VPA alone and VPA in combination with PEG-IFNa increased the expression of interferon-alpha receptor and interferon regulatory factor 8. Conclusion: The combination of VPA and PEG-IFN alpha can be useful for the treatment of pancreatic cancer.

引用

页码：3403 / 3409

页数：7

共 50 条

[41] SORAFENIB ENHANCES THE ANTI-TUMOR EFFECT OF ANTI-CTLA-4 ANTIBODY TO KIDNEY CANCER
Takanobu, Motoshima
Yoshihiro, Komohara
Yoshiaki, Kawano
Yoshihiro, Wada
Masatoshi, Eto
JOURNAL OF UROLOGY, 2013, 189 (04): : E66 - E66
[42] Enhanced anti-tumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer
Ahn, D-W
Seo, J. K.
Lee, S. H.
Hwang, J-H
Lee, J. K.
Ryu, J. K.
Kim, Y-T
Yoon, Y. B.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 241 - 241
[43] Interferon-α promotes the anti-proliferative effect of gefitinib (ZD1839) on human colon cancer cell lines
Yang, JL
Qu, XJ
Russell, PJ
Goldstein, D
ONCOLOGY, 2005, 69 (03) : 224 - 238
[44] Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer
Lee, Sang Hyub
Ryu, J. Kon
Lee, Kyeung-Yeup
Woo, Sang Myung
Park, Joo Kyung
Yoo, Ji Won
Kim, Yong-Tae
Yoon, Yong Bum
CANCER LETTERS, 2008, 259 (01) : 39 - 49
[45] Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines
Ryuichiro Koshimune
Motoi Aoe
Shinichi Toyooka
Fumikata Hara
Mamoru Ouchida
Masaki Tokumo
Yoshifumi Sano
Hiroshi Date
Nobuyoshi Shimizu
BMC Cancer, 7
[46] Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines
Koshimune, Ryuichiro
Aoe, Motoi
Toyooka, Shinichi
Hara, Fumikata
Ouchida, Mamoru
Tokumo, Masaki
Sano, Yoshifumi
Date, Hiroshi
Shimizu, Nobuyoshi
BMC CANCER, 2007, 7 (1)
[47] Combined Usage of MDK Inhibitor Augments Interferon-γ Anti-Tumor Activity in the SKOV3 Human Ovarian Cancer Cell Line
Liu, Qun
Tan, Jingyu
Zhao, Zhenguo
Li, Ruijun
Zheng, Luyu
Chen, Xiangyu
Li, Lina
Dong, Xichen
Wen, Tao
Liu, Jian
BIOMEDICINES, 2023, 11 (01)
[48] Ecsod Enhances the Anti-Tumor Effect of LMWH in Breast Cancer by Preventing Cell Surface Heparan Sulfate Degradation
Teoh, Melissa
Fitzgerald, Matthew Paul
Oberley, Larry W.
Domann, Frederick E.
FREE RADICAL BIOLOGY AND MEDICINE, 2008, 45 : S57 - S57
[49] IL-7 enhances the anti-tumor response in nonsmall cell lung cancer
Yang, Seok Chul
Kim, Young Whan
You, Chul-Gyu
Lee, San Min
Lee, Choon-Taek
Han, Sung Koo
Shim, Young-Soo
Lim, Jae-Jun
Hillinger, Sven
Zhu, Li
Dubinett, Steven M.
Sharma, Sherven
CHEST, 2007, 132 (04) : 458S - 458S
[50] Downregulation of miR-486-5p Enhances the Anti-Tumor Effect of 5-Fluorouracil on Pancreatic Cancer Cells
Wang, Wei
Liu, Bowei
Sun, Suofeng
Lan, Ling
Chen, Yu
Han, Shuangyin
Li, Xiuling
Li, Zhaoshen
ONCOTARGETS AND THERAPY, 2020, 13 : 1649 - 1659

← 1 2 3 4 5 →